Antiglycolipid antibodies in motor neuropathies

Nicole Baumann, Marie Luce Harpin, Yannick Marie, Karine Lemerle, Benedicte Chassande, Pierre Bouche, Vincent Meininger, Robert K. Yu, Jean Marc Léger

Research output: Contribution to journalArticle

18 Scopus citations

Abstract

In peripheral neuropathies with monoclonal gammopathy, mainly IgM, it appears clear from clinical, electrophysiological, and experimental data, that the target glycolipid or glycolipid epitope for the IgM is related to the type of neuropathy - purely sensory, predominantly sensory, or uniquely motor. Investigations have focused on chronic peripheral neuropathies associated with polyclonal IgM reactivity to glycolipids. Although IgM anti-GM1 antibodies are present in normal controls, there is a subgroup of motor neuropathies with high titer anti-GM1 antibodies, mainly multifocal neuropathies with conduction blocks (MMNCB). Another subgroup of MMNCB may include IgM anti-SGPG antibodies that do not cross-react with MAG. The importance of the fine structure of the epitope has to be considered in view of the pathogenicity of the antibody. It may bear consequences on its binding properties on the neuronal surfaces and on its biological implications.

Original languageEnglish (US)
Pages (from-to)322-329
Number of pages8
JournalAnnals of the New York Academy of Sciences
Volume845
DOIs
StatePublished - Jan 1 1998
Externally publishedYes

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • History and Philosophy of Science

Fingerprint Dive into the research topics of 'Antiglycolipid antibodies in motor neuropathies'. Together they form a unique fingerprint.

  • Cite this

    Baumann, N., Harpin, M. L., Marie, Y., Lemerle, K., Chassande, B., Bouche, P., Meininger, V., Yu, R. K., & Léger, J. M. (1998). Antiglycolipid antibodies in motor neuropathies. Annals of the New York Academy of Sciences, 845, 322-329. https://doi.org/10.1111/j.1749-6632.1998.tb09684.x